Medicare Part D Subsidy Expires Next Year, Retirees Should Watch for Premium Changes

特朗普放弃减肥药物提案,两大巨头股价下滑
Published on: Aug 22, 2026
Author: Amy Liu

The U.S. Centers for Medicare & Medicaid Services (CMS) recently announced that it will terminate a temporary subsidy program for Part D prescription drug plans effective January 2027. This move means that Medicare beneficiaries with stand-alone prescription drug plans may face upward pressure on premiums next year.

The subsidy program, named the “Part D Premium Stabilization Demonstration,” operated from 2025 through 2026 and was designed to lower Part D premiums for older adults and limit annual premium increases. Over the past two years, most beneficiaries with Part D plans realized actual cost savings from this program. With the subsidy ending in late 2026, the magnitude of Part D premium increases in 2027 may be significantly higher than in prior years, adding new uncertainty to already burdensome retirement healthcare expenses.

Make the Most of the Open Enrollment Period and Proactively Compare Available Options

Although the specific premium increases for Part D in 2027 are not yet known, beneficiaries can take full advantage of this year’s Medicare Open Enrollment Period, which runs from October 15 to December 7, to comprehensively review and adjust their plans. During this window, enrollees may select new coverage for the following year or switch between Original Medicare and Medicare Advantage plans. It is advisable to make full use of this period to compare the coverage scope and prices of different plans, with particular attention to confirming that regularly used medications are included on formularies, in order to select the most cost-effective option.

Use Multiple Channels to Reduce Drug Costs and Plan Annual Budgets in Advance

In addition to adjusting insurance plans, beneficiaries can control drug expenditures through other means. For example, consult with physicians or pharmacists about available generic alternatives, utilize manufacturer discount coupons, or compare prices across different retail pharmacies. Some pharmaceutical companies also offer specialized financial assistance programs for older adults or low-income populations; those who qualify are encouraged to proactively apply.

After determining next year’s Part D premiums and other related healthcare costs, it is advisable to develop a personal financial budget for 2027 as early as possible. At the same time, it is worth noting that Social Security benefits will also see an upward adjustment next year, and this additional income may partially offset rising medical expenses, thereby easing financial pressure on retirees. For specific details regarding plan changes, timely communication with insurance providers can help avoid subsequent confusion and unexpected out-of-pocket costs.

Healthcare Services Life Science Nutraceutical Pharmaceutical